These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38952145)

  • 1. A Real-world Study of Denosumab For Reducing Refracture Risk after Percutaneous Vertebral Augmentation.
    Zou J; Zhang Y; Niu J; Song D; Huang Z; Li Z; Liu T; Meng B; Shi Q; Zhu X; Yang H
    Orthop Surg; 2024 Aug; 16(8):1849-1860. PubMed ID: 38952145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Fracture Liaison Service Program in Reducing Refracture Rate in the Elderly Osteoporotic Trauma Patients Presenting With Vertebral Compression Fracture: A Six-Year Study.
    Kelm N; Wasfie T; Volk M; Walker Z; Galovska S; Brock C; Jackson A
    Am Surg; 2023 Apr; 89(4):784-788. PubMed ID: 34551600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risk factors of vertebral refracture after kyphoplasty in patients with osteoporotic vertebral compression fractures: a study protocol for a prospective cohort study.
    Feng L; Feng C; Chen J; Wu Y; Shen JM
    BMC Musculoskelet Disord; 2018 Jul; 19(1):195. PubMed ID: 29961425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness and safety outcomes between denosumab and bisphosphonate in South Korea.
    Park C; Kim C; Park RW; Jeon JY
    J Bone Miner Res; 2024 Aug; 39(7):835-843. PubMed ID: 38722817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of percutaneous kyphoplasty with different phases bone cement for treatment of osteoporotic vertebral compression fractures].
    Liu Z; Zhou Y; Lei F; Ye F; Zhou Q; Zheng L; Feng D
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2020 Apr; 34(4):435-441. PubMed ID: 32291977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Logistic regression analysis on risk factors of augmented vertebra recompression after percutaneous vertebral augmentation.
    An Z; Chen C; Wang J; Zhu Y; Dong L; Wei H; Wu L
    J Orthop Surg Res; 2021 Jun; 16(1):374. PubMed ID: 34116683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robot-assisted percutaneous vertebroplasty for osteoporotic vertebral compression fracture treatment and risk factor screening for postoperative refracture.
    Liu D; Zhang H; Fan X
    J Robot Surg; 2024 Jan; 18(1):23. PubMed ID: 38217736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of refracture risk between sandwich vertebrae and ordinary adjacent vertebrae].
    Liu J; Tang J; Chen G; Gu Z; Zhang Y; Yu S; Liu H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2021 Sep; 35(9):1161-1166. PubMed ID: 34523282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors of cemented vertebral refracture after percutaneous vertebral augmentation: a systematic review and meta-analysis.
    Zhu S; Su Q; Zhang Y; Sun Z; Yin P; Hai Y
    Neuroradiology; 2020 Nov; 62(11):1353-1360. PubMed ID: 32683478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk factors of adjacent vertebral refracture after percutaneous vertebroplasty for osteoporotic vertebral compression fractures in super-old patients].
    Hu H; Cao KX; Huang P; Huang CW; Wan LL; Yi LY; Pu FF
    Zhongguo Gu Shang; 2022 Aug; 35(8):710-4. PubMed ID: 35979761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation.
    Davis S; Simpson E; Hamilton J; James MM; Rawdin A; Wong R; Goka E; Gittoes N; Selby P
    Health Technol Assess; 2020 Jun; 24(29):1-314. PubMed ID: 32588816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A nomogram prediction model for refracture in elderly patients with osteoporotic vertebral compression fractures after percutaneous vertebroplasty.
    Ju G; Liu X
    Eur Spine J; 2023 Nov; 32(11):3919-3926. PubMed ID: 37395782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and risk factors of subsequent vertebral fracture following percutaneous vertebral augmentation in postmenopausal women.
    Cheng Y; Chen X; Li Y; Tan Z; Yao X; Jiang R; Wu H
    Eur Spine J; 2024 Jun; ():. PubMed ID: 38853178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous Curved Vertebroplasty Decrease the Risk of Cemented Vertebra Refracture Compared with Bilateral Percutaneous Kyphoplasty in the Treatment of Osteoporotic Vertebral Compression Fractures.
    Zhou Q; Wan Y; Ma L; Dong L; Yuan W
    Clin Interv Aging; 2024; 19():289-301. PubMed ID: 38434576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiological and clinical characteristics analysis of 681 cases of thoracolumbar osteoporotic vertebral compression fractures].
    Chen H; Pan W; Zhang Y; Xing C; Zhang B; Sun B; Zhen Z; Gong L; Xu H
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2022 Jul; 36(7):873-880. PubMed ID: 35848185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistance and Compliance with Osteroporosis Therapies Among Women in a Commercially Insured Population in the United States.
    Cheng LI; Durden E; Limone B; Radbill L; Juneau PL; Spangler L; Mirza FM; Stolshek BS
    J Manag Care Spec Pharm; 2015 Sep; 21(9):824-33, 833a. PubMed ID: 26308229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased fracture risk after discontinuation of anti-osteoporosis medications among hip fracture patients: A population-based cohort study.
    Fu SH; Wang CY; Hung CC; Lee CC; Yang RS; Huang CC; Farn CJ; Lin WH; Chen HM; Hsiao FY; Lin JW; Li CY
    J Intern Med; 2021 Dec; 290(6):1194-1205. PubMed ID: 34237171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world effectiveness of osteoporosis treatments in Germany.
    O'Kelly J; Bartsch R; Kossack N; Borchert J; Pignot M; Hadji P
    Arch Osteoporos; 2022 Aug; 17(1):119. PubMed ID: 36044096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refracture risk and all-cause mortality after vertebral fragility fractures: Anti-osteoporotic medications matter.
    Tai TW; Tsai YL; Shih CA; Li CC; Chang YF; Huang CF; Cheng TT; Hwang JS; Lu TH; Wu CH
    J Formos Med Assoc; 2023; 122 Suppl 1():S65-S73. PubMed ID: 37120337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study.
    Everts-Graber J; Bonel H; Lehmann D; Gahl B; Häuselmann H; Studer U; Ziswiler HR; Reichenbach S; Lehmann T
    Osteoporos Int; 2023 Nov; 34(11):1961-1973. PubMed ID: 37493978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.